A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
PHASE1
This is a pilot clinical trial investigating the addition of haploidentical...
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody
N/A
Hu14.18K322A is a monoclonal antibody developed at St. Jude Children's Rese...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2014-07-15
Trial ID
NCT02159443
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
PHASE2
The study participant is being asked to take part in this research study be...